|4Feb 12, 4:13 PM ET

GENEREX BIOTECHNOLOGY CORP 4

4 · GENEREX BIOTECHNOLOGY CORP · Filed Feb 12, 2016

Insider Transaction Report

Form 4
Period: 2016-02-09
FELLOWS STEPHEN
Acting CFO
Transactions
  • Exercise/Conversion

    Common Stock Purchase Option

    2016-02-09+1,667,6711,667,671 total
    Exercise: $0.00From: 2016-02-09Exp: 2020-10-26Common Stock (1,667,671 underlying)

Documents

1 file
  • 4
    fellows021216form4.xmlPrimary

    FORM 4